ARTICLE | Clinical News
Cornerstone Pharmaceuticals preclinical data
October 10, 2011 7:00 AM UTC
In mouse xenograft models of melanoma and non-small cell lung cancer (NSCLC), EmPAC produced greater tumor growth inhibition than that of Taxol paclitaxel. In rabbits, a single IV injection of 22.5 m...